Abramson David H, Marr Brian P, Brodie Scott E, Dunkel Ira J, Lin Amy, Folberg Robert, Gobin Y Pierre
Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
Open Ophthalmol J. 2012;6:1-3. doi: 10.2174/1874364101206010001. Epub 2012 Jan 19.
Massive intraocular hemorrhage developed in a child with advanced unilateral retinoblastoma after intrarterial treatment with Melphalan and Topotecan. The child tested positive for sickle cell trait. Sickle cell trait may predispose such children to slower vascular transit time, hypoxia, sickling and vascular occlusion caused by catheter induced decreased flow. Enucleation confirmed the ultrasound and selective angiogram findings in addition to a completely calcified tumor. Clinicians should be on the lookout for the association of sickle-cell disease/trait and intraocular hemorrhages after intraarterial chemotherapy to fully understand its clinical significance.
一名患有晚期单侧视网膜母细胞瘤的儿童在接受美法仑和拓扑替康动脉内治疗后发生了大量眼内出血。该儿童镰状细胞性状检测呈阳性。镰状细胞性状可能使此类儿童更容易出现血管运输时间延长、缺氧、镰状化以及由导管导致的血流减少引起的血管闭塞。除了一个完全钙化的肿瘤外,眼球摘除术证实了超声和选择性血管造影的结果。临床医生应留意镰状细胞病/性状与动脉内化疗后眼内出血之间的关联,以充分了解其临床意义。